ReviewDiabetes2021

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Katherine R Tuttle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.